By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today said that the Nasdaq Stock Market has approved the firm's switch to the Nasdaq Capital Market from the Nasdaq Global Market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.